Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Attention deficit/hyperactivity disorder and psychopharmacologic treatments in the athlete.

Conant-Norville DO, Tofler IR.

Clin Sports Med. 2005 Oct;24(4):829-43, viii. Review.

PMID:
16169448
2.

Attention deficit hyperactivity disorder, CNS stimulants and sport.

Hickey G, Fricker P.

Sports Med. 1999 Jan;27(1):11-21. Review.

PMID:
10028130
3.

Attention-deficit-hyperactivity disorder: an update.

Dopheide JA, Pliszka SR.

Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Review.

PMID:
19476419
4.

Medications for adolescents with attention-deficit/hyperactivity disorder.

Soileau EJ Jr.

Adolesc Med State Art Rev. 2008 Aug;19(2):254-67, viii-ix. Review.

PMID:
18822831
5.

Attention deficit hyperactivity disorder in sport: a review.

Corrigan B.

Int J Sports Med. 2003 Oct;24(7):535-40. Review.

PMID:
12968213
6.

Adults with attention deficit hyperactivity disorder: assessment and treatment considerations.

Murphy K.

Semin Speech Lang. 1996 Aug;17(3):245-53; quiz 254. Review.

PMID:
8912439
7.
8.

ADHD and the rise in stimulant use among children.

Mayes R, Bagwell C, Erkulwater J.

Harv Rev Psychiatry. 2008;16(3):151-66. doi: 10.1080/10673220802167782. Review.

PMID:
18569037
9.

National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan.

Gau SS, Chen SJ, Chou WJ, Cheng H, Tang CS, Chang HL, Tzang RF, Wu YY, Huang YF, Chou MC, Liang HY, Hsu YC, Lu HH, Huang YS.

J Clin Psychiatry. 2008 Jan;69(1):131-40.

PMID:
18312048
11.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
12.

Update on adult attention-deficit/hyperactivity disorder.

Hammerness P, Surman C, Miller K.

Curr Neurol Neurosci Rep. 2008 Nov;8(6):484-9.

PMID:
18957185
13.

Pharmacologic treatment of attention-deficit hyperactivity disorder.

Greydanus DE.

Indian J Pediatr. 2005 Nov;72(11):953-60. Review.

PMID:
16391451
14.

Pharmacology of adult ADHD with stimulants.

Spencer TJ.

CNS Spectr. 2007 Apr;12(4 Suppl 6):8-11. No abstract available.

PMID:
17715564
15.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
16.
17.

Treatment of adult ADHD and comorbid disorders.

Young JL.

CNS Spectr. 2006 Oct;11(10 Suppl 11):10-2. No abstract available.

PMID:
17712918
18.

ADHD in children, adolescents, and adults.

Katragadda S, Schubiner H.

Prim Care. 2007 Jun;34(2):317-41; abstract viii. Review.

PMID:
17666230
19.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
20.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941

Supplemental Content

Support Center